1. Home
  2. LGIH vs SANA Comparison

LGIH vs SANA Comparison

Compare LGIH & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$47.83

Market Cap

1.2B

ML Signal

HOLD

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

HOLD

Current Price

$5.22

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
SANA
Founded
2003
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
LGIH
SANA
Price
$47.83
$5.22
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$71.13
$7.83
AVG Volume (30 Days)
330.9K
5.2M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.53
N/A
Revenue
$1,788,933,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.77
N/A
P/E Ratio
$10.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.70
$1.26
52 Week High
$104.31
$7.30

Technical Indicators

Market Signals
Indicator
LGIH
SANA
Relative Strength Index (RSI) 46.65 61.91
Support Level $46.73 $4.25
Resistance Level $50.54 $5.43
Average True Range (ATR) 2.17 0.50
MACD -0.36 0.13
Stochastic Oscillator 10.77 87.35

Price Performance

Historical Comparison
LGIH
SANA

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Share on Social Networks: